Dr. Michael Y. Lin, MD
Critical Care Medicine (Critical Care Medicine (Anesthesiology) Physician)
700 Lawrence Expy
Santa Clara, CA 95051
Who else practices at this address →
Santa Clara County includes mental health (13% of residents) shortage areas. About shortage areas
At a glance
- Medical school
- University of California, San Francisco School of Medicine (2012)
- Years since graduation
- 14
- In the NPI registry since
- 2012
Licensed in California since 2013, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Medical school: University of California, San Francisco School of Medicine
- 2012Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Critical Care Medicine (Anesthesiology) Physician primary
CA license A126712 (first issued 2013; current) -
Anesthesiology Physician
CA license A126712 (first issued 2013; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Kaiser Foundation Hospital-Santa Clara Santa Clara, CA
Medical groups
- Permanente Medical Group Inc (10,996 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $22.60 in total to this clinician.
| Incyte Corporation | $22.60 |
|---|
| Food and Beverage | $22.60 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $74,204 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo
Incyte Corporation - A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, EfficacyAnd Safety of Ruxolitinib Cream in Participants with Prurigo Nodularis
Incyte Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.